Home › Stem Cells

Stem Cells

News Story
10/31/2014
Posted by Mark Reback
The thorny and unresolved question of whether life itself can be patented may come again before the U.S. Supreme Court, if it accepts a motion filed Friday by Santa Monica-based Consumer Watchdog. (H/T to David Jensen's California Stem Cell Report.) The issue isn't a new one either for the consumer group or the Court. Consumer Watchdog...
News Story
10/30/2014
Posted by Mark Reback
The California-based  challenge to WARF’s patent on human embryonic stem cells is headed for the United States Supreme Court.   The nation’s highest court is expected to be asked Friday to overturn an earlier appellate court decision and allow two public interest groups to seek to cancel the patent held by WARF, the Wisconsin...
News Story
10/30/2014
Posted by Mark Reback
The U.S. Supreme Court will be asked to intervene over a controversial embryonic stem cell patent, opponents of the patent said Thursday. Jeanne Loring, a stem cell scientist at The Scripps Research Institute, said the court will be asked Friday to overturn a lower court decision and allow the opponents to seek cancellation of the patent held by...
News Story
7/24/2014
Posted by Mark Reback
Responding to his predecessor's ethically controversial departure, the president and chief executive of California's stem cell agency said Thursday he is taking legal steps to minimize conflicts of interests with those who have business before the agency. C. Randal Mills said he will not take a job with any company funded by the...
News Story
7/24/2014
Posted by Mark Reback
In the wake of the former president of California's stem cell research funding agency jumping to the board of a company the agency funded, his successor declared he will not accept a job with any company funded by the agency within a year of leaving the post or accept gifts or travel from any company, institution or individual that receives...
News Story
7/18/2014
Posted by Mark Reback
Given the way Washington has run away with itself, it’s no surprise that “crony capitalism” has risen to the top of the agenda for some politicians on the political left as well as the political right. The federal government has become a virtual one-stop shop for corporations more interested in gaming the system and capturing...
News Story
7/14/2014
Posted by Mark Reback
California's stem cell research funding agency needs a home run to score more public funding. Instead, a conflict-of-interest problem is giving it the wrong kind of attention. The latest embarrassment for the San Francisco-based California Institute for Regenerative Medicine is what's quickly becoming known as the "Trounson Affair....
News Story
7/10/2014
Posted by Mark Reback
California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. Newark, Calif.-based StemCells Inc. announced that Alan Trounson would be joining its board of directors a...
News Story
7/9/2014
Posted by Mark Reback
Trounson goes to work for StemCells Inc., which has received $19.4M Alan Trounson, then president of the California Institute for Regenerative Medicine, poses for a portrait at his offices in San Francisco, Monday, March 9, 2009. (AP Photo/Eric Risberg) — AP The former head of California's stem cell agency, which is handing out $3...
News Story
7/9/2014
Posted by Mark Reback
Two days after the ex-president of California’s stem cell agency became a board director at a company that is receiving funding from the agency, the agency said Wednesday it is taking steps to “mitigate a potential conflict of interest.” Earlier this week, StemCells Inc. in Newark said that Dr. Alan Trounson would join its board...